Clinical Trial

Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease

Study acronym: PD-HemON
Recruiting
View on ClinicalTrials.gov →
Summary
The PD-HemON study aims to evaluate the safety and preliminary efficacy of ARC-IM Therapy (Epidural Electrical Stimulation) to support hemodynamic management in people with typical and atypical Parkinson's Disease, who suffer from orthostatic hypotension.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-04-02; most recent amendment 2026-07-02.
Status change: Not Yet Recruiting → Recruiting 2025-07-22
Trial Details
NCT Number NCT06920134
Lead Sponsor Ecole Polytechnique Fédérale de Lausanne
Conditions Hypotension Symptomatic, Parkinson's Disease, Orthostatic Hypotension, Dysautonomic, Multiple System Atrophy (MSA) With Orthostatic Hypotension, Multiple System Atrophy - Parkinsonian Subtype (MSA-P)
Enrollment 5 participants
Start Date 2025-07-03
Primary Completion 2031-05-01 (estimated)
Study Completion 2031-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-07